Work

Aberrant p53 Staining Does Not Predict Cisplatin Resistance in Locally Advanced Non-Small Cell Lung Cancer

Year: 2002

Type: article

Source: Cancer Investigation

DOI: 10.1081/cnv-120003537

Authors: Elizabeth A. Johnson, David S. Klimstra, James E. Herndon II, Edison Catalano, George P. Canellos, Stephen L. Graziano, Jeffrey A. Kern, Mark R. Green

Institutions: Mayo Clinic, Mayo Clinic in Florida, Memorial Sloan Kettering Cancer Center, Cooper University Hospital, SUNY Upstate Medical University, University of Iowa, University of Iowa Hospitals and Clinics, Medical University of South Carolina

Language: English

Topic: Lung Cancer Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute

Awards: G237383067, Cancer and Leukemia Group B, G2647518335, Cancer and Leukemia Group B Statistical Center, Cancer and Leukemia Group B, CANCER AND LEUKEMIA GROUP B, G739544170, G877907214

OpenAlex ID: W2115183352

FWCI: 0.819

Cites: 16

Cited by: 11

Related to: 10